What are the best treatments for Ovarian cancer?

The standard treatment for ovarian cancer typically involves a combination of cytoreductive surgery to remove as much tumor tissue as possible, followed by platinum-based chemotherapy. Because ovarian cancer is a complex disease, treatment must be highly personalized based on the cancer's stage, molecular profile, and the patient's overall health.

What are the primary treatments for ovarian cancer?

For most patients diagnosed with ovarian cancer, the frontline approach is "debulking" or cytoreductive surgery, aimed at removing all visible disease. This is usually followed by systemic chemotherapy to target microscopic cells. Medications commonly used include platinum-based agents like carboplatin or cisplatin, often combined with taxanes such as paclitaxel (Taxol).

How is ovarian cancer treated with targeted therapies?

Recent advancements have revolutionized the management of ovarian cancer through targeted therapies. These treatments are often selected based on genetic testing, such as BRCA1/2 mutation status. Key therapies include:

• PARP inhibitors: Medications like olaparib (Lynparza), niraparib (Zejula), and rucaparib (Rubraca) which prevent cancer cells from repairing their DNA.


• Anti-angiogenesis agents: Bevacizumab (Avastin), which helps starve the tumor by inhibiting the growth of new blood vessels.

Which specialists should be on the care team?

Managing ovarian cancer requires a multidisciplinary team to ensure the best outcomes. Your care team should include a gynecologic oncologist (who specializes in reproductive cancers), a radiation oncologist, a medical oncologist, a clinical geneticist, and a palliative care specialist to manage symptoms and quality of life.

What is the role of clinical trials?

Research is rapidly evolving, and many patients with ovarian cancer choose to participate in clinical trials to access novel immunotherapies or antibody-drug conjugates. These trials investigate new ways to overcome treatment resistance and improve survival rates for those with recurrent disease.

Next steps

• Consult with a board-certified gynecologic oncologist to discuss your specific surgical and chemotherapy options.


• Undergo genetic counseling and tumor profiling to determine if you are a candidate for targeted therapies.


• Join the 60 members of the DiseaseMaps.org ovarian cancer community to share experiences and find peer support.

Medical disclaimer: This information is for educational purposes only and does not constitute medical advice; always consult your oncology team for personalized treatment decisions.

References

• NIH National Cancer Institute (NCI) - Ovarian Cancer Treatment Guidelines


• American Cancer Society - Detailed Guide to Ovarian Cancer


• National Comprehensive Cancer Network (NCCN) - Clinical Practice Guidelines in Oncology


• Ovarian Cancer Research Alliance (OCRA)